Corrigendum to “The Long-Term Safety and Efficacy of Vestronidase Alfa, Rhgus Enzyme Replacement Therapy, in Subjects with Mucopolysaccharidosis Vii” [Mol Genet Metab 2020 Mar;129(3):219–227] (Molecular Genetics and Metabolism (2020) 129(3) (219–227), (S1096719219307851), (10.1016/J.ymgme.2020.01.003))